Fluticasone propionate (intranasal)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Fluticasone propionate (intranasal), covering 2015-07-23 to 2018-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety [Phase 3]